E
ELV icon

Ergoteles’s Elevance Health ELV Stock Holding History

Ergoteles’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,731
Closed -$3.88M – 292
2023
Q2 		$3.88M Buy
8,731
+6,075
+229% +$2.8M 0.19% 134
2023
Q1 		$1.22M Buy
+2,656
New +$1.26M 0.05% 423
2021
Q3 		– Sell
-25,067
Closed -$9.57M – 1335
2021
Q2 		$9.57M Sell
25,067
-21,689
-46% -$8.29M 0.22% 137
2021
Q1 		$16.8M Sell
46,756
-8,447
-15% -$2.72M 0.52% 48
2020
Q4 		$17.7M Buy
+55,203
New +$16.9M 0.59% 42

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ergoteles's ELV Position: Q3 2023 in Review

Ergoteles sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 8,731 shares — an estimated $3.88M sold.

Ergoteles first reported a position in ELV in Q4 2020 and held it in 5 quarters. The position peaked at $17.7M in Q4 2020. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Ergoteles reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 8,731 Elevance Health shares in Q3 2023, an estimated $3.88M.
  • Ergoteles first reported a position in Elevance Health in Q4 2020 and held it in 5 quarters.
  • Ergoteles's Elevance Health position peaked at $17.7M in Q4 2020.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.